Literature DB >> 11032860

CD4 T cell-mediated cardiac allograft rejection requires donor but not host MHC class II.

B A Pietra1, A Wiseman, A Bolwerk, M Rizeq, R G Gill.   

Abstract

Numerous studies indicate that CD4 T cells are required for acute cardiac allograft rejection. However, the precise role for CD4 T cells in this response has remained ambiguous owing to the multipotential properties of this T-cell subpopulation. In the current study, we demonstrate the capacity of CD4 T cells to serve as direct effector cells of cardiac allograft rejection. We show that CD4 T cells are both necessary and sufficient for acute graft rejection, as indicated by adoptive transfer experiments in immune-deficient SCID and rag1(-/-) recipients. We have analyzed the contribution of direct (donor MHC class II restricted) and indirect (host MHC class II restricted) antigen recognition in CD4-mediated rejection. Acute CD4 T cell-mediated rejection required MHC class II expression by the allograft, indicating the importance of direct graft recognition. In contrast, reciprocal experiments indicate that CD4 T cells can acutely reject allogeneic cardiac allografts established in rag1(-/-) hosts that were also MHC class II deficient. This latter result indicates that indirect presentation of donor antigens by host MHC class II is not required for acute CD4-mediated rejection. Taken together, these results indicate that CD4 T cells can serve as effector cells for primary acute cardiac allograft rejection, predominantly via direct donor antigen recognition and independent of indirect reactivity.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11032860      PMCID: PMC314344          DOI: 10.1172/JCI10467

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  40 in total

1.  Successful secondary heterotopic cardiac transplantation in the mouse.

Authors:  T C Pearson; C R Darby; K J Wood
Journal:  Transplantation       Date:  1992-03       Impact factor: 4.939

2.  Depletion of CD4+ T cells in major histocompatibility complex class II-deficient mice.

Authors:  M J Grusby; R S Johnson; V E Papaioannou; L H Glimcher
Journal:  Science       Date:  1991-09-20       Impact factor: 47.728

3.  The scid mouse mutant.

Authors:  M Bosma; W Schuler; G Bosma
Journal:  Curr Top Microbiol Immunol       Date:  1988       Impact factor: 4.291

4.  Strategies of monoclonal antibody therapy that induce permanent tolerance of organ transplants.

Authors:  J Herbert; B Roser
Journal:  Transplantation       Date:  1988-08       Impact factor: 4.939

5.  Tissue-specific effects of anti-CD4 therapy in induction of allograft unresponsiveness in high and low responder rats.

Authors:  D Yin; C G Fathman
Journal:  Transpl Immunol       Date:  1995-09       Impact factor: 1.708

6.  Characterization of the murine T cell surface molecule, designated L3T4, identified by monoclonal antibody GK1.5: similarity of L3T4 to the human Leu-3/T4 molecule.

Authors:  D P Dialynas; Z S Quan; K A Wall; A Pierres; J Quintáns; M R Loken; M Pierres; F W Fitch
Journal:  J Immunol       Date:  1983-11       Impact factor: 5.422

7.  Tolerance in the mouse to major histocompatibility complex-mismatched heart allografts, and to rat heart xenografts, using monoclonal antibodies to CD4 and CD8.

Authors:  Z Chen; S Cobbold; S Metcalfe; H Waldmann
Journal:  Eur J Immunol       Date:  1992-03       Impact factor: 5.532

8.  Indefinite survival of MHC class I-deficient murine pancreatic islet allografts.

Authors:  J F Markmann; H Bassiri; N M Desai; J S Odorico; J I Kim; B H Koller; O Smithies; C F Barker
Journal:  Transplantation       Date:  1992-12       Impact factor: 4.939

9.  Induction of donor-specific unresponsiveness to cardiac allografts in rats by pretransplant anti-CD4 monoclonal antibody therapy.

Authors:  J A Shizuru; K B Seydel; T F Flavin; A P Wu; C C Kong; E G Hoyt; N Fujimoto; M E Billingham; V A Starnes; C G Fathman
Journal:  Transplantation       Date:  1990-09       Impact factor: 4.939

10.  Rejection of skin allografts by indirect allorecognition of donor class I major histocompatibility complex peptides.

Authors:  J Fangmann; R Dalchau; J W Fabre
Journal:  J Exp Med       Date:  1992-06-01       Impact factor: 14.307

View more
  54 in total

Review 1.  Cellular and molecular basis of inflammatory myocardial disease.

Authors:  W H Barry
Journal:  J Nucl Cardiol       Date:  2001 Jul-Aug       Impact factor: 5.952

2.  A two-step model of acute CD4 T-cell mediated cardiac allograft rejection.

Authors:  Todd J Grazia; Biagio A Pietra; Zachary A Johnson; Brian P Kelly; Robert J Plenter; Ronald G Gill
Journal:  J Immunol       Date:  2004-06-15       Impact factor: 5.422

Review 3.  Allopeptides and the alloimmune response.

Authors:  Ankit Bharat; T Mohanakumar
Journal:  Cell Immunol       Date:  2007-07       Impact factor: 4.868

4.  Constraints in antigen presentation severely restrict T cell recognition of the allogeneic fetus.

Authors:  Adrian Erlebacher; Daniela Vencato; Kelly A Price; Dorothy Zhang; Laurie H Glimcher
Journal:  J Clin Invest       Date:  2007-04-19       Impact factor: 14.808

5.  CD4+ T lymphocytes are not necessary for the acute rejection of vascularized mouse lung transplants.

Authors:  Andrew E Gelman; Mikio Okazaki; Jiaming Lai; Christopher G Kornfeld; Friederike H Kreisel; Steven B Richardson; Seiichiro Sugimoto; Jeremy R Tietjens; G Alexander Patterson; Alexander S Krupnick; Daniel Kreisel
Journal:  J Immunol       Date:  2008-04-01       Impact factor: 5.422

6.  Spontaneous allograft tolerance in B7-deficient mice independent of preexisting endogenous CD4+CD25+ regulatory T-cells.

Authors:  Todd J Grazia; Robert J Plenter; An N Doan; Brian P Kelly; Sarah M Weber; Jonathan S Kurche; Susan O Cushing; Ronald G Gill; Biagio A Pietra
Journal:  Transplantation       Date:  2007-06-15       Impact factor: 4.939

7.  Pancreatic islets engineered with a FasL protein induce systemic tolerance at the induction phase that evolves into long-term graft-localized immune privilege.

Authors:  Kyle B Woodward; Hong Zhao; Pradeep Shrestha; Lalit Batra; Min Tan; Orlando Grimany-Nuno; Laura Bandura-Morgan; Nadir Askenasy; Haval Shirwan; Esma S Yolcu
Journal:  Am J Transplant       Date:  2020-01-05       Impact factor: 8.086

8.  Ectopic expression of Fas Ligand on cardiomyocytes renders cardiac allografts resistant to CD4(+) T-cell mediated rejection.

Authors:  Robert J Plenter; Todd J Grazia; David P Nelson; Martin R Zamora; Ronald G Gill; Biagio A Pietra
Journal:  Cell Immunol       Date:  2014-12-06       Impact factor: 4.868

9.  Donor exosomes rather than passenger leukocytes initiate alloreactive T cell responses after transplantation.

Authors:  Jose Marino; Mohamed H Babiker-Mohamed; Patrick Crosby-Bertorini; Joshua T Paster; Christian LeGuern; Sharon Germana; Reza Abdi; Mayuko Uehara; James I Kim; James F Markmann; Georges Tocco; Gilles Benichou
Journal:  Sci Immunol       Date:  2016-07-14

Review 10.  Direct and indirect allograft recognition: pathways dictating graft rejection mechanisms.

Authors:  Christine M Lin; Ronald G Gill
Journal:  Curr Opin Organ Transplant       Date:  2016-02       Impact factor: 2.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.